Product
Treated without
1 clinical trial
6 indications
Indication
COVID-19Indication
OutcomeIndication
FatalIndication
TocilizumabIndication
IL-6Indication
Critically IllClinical trial
Course of Inflammation and Infection Markers in Critically Ill ICU Patients Under Casirivimab- and/or Tocilizumab ApplicationStatus: Completed, Estimated PCD: 2022-04-28